Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Brevundimonas sp. 374

PROVIDER: PRJEB16109 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	FNKT01.dat.gz	Other
	FNKT01.fasta.gz	Fasta.gz
	FNKT01.master.dat	Other
	FNKT01.dat.gz	Other

Items per page:

1 - 4 of 4

Similar Datasets

Brevundimonas sp. 374

Project description:Brevundimonas sp. 374 Genome sequencing

| PRJNA182414 | ENA

Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats

Project description:Gut microbiota modulation by a probiotic is a novel therapy for hypercholesterolemia mitigation. This study initially investigated the potential hypocholesterolemic effect of Bacillus sp. DU-106 in hypercholesterolemic rats and explored its potential relation with gut microbiota. Sprague-Dawley rats received a high-fat diet, or a high-fat diet supplemented with 7.5 × 109 and 1.5 × 1010 CFU/kg bw/day Bacillus sp. DU-106 (low-dose and high-dose groups). At the end of 9 weeks, Bacillus sp. DU-106 treatment significantly decreased the body weight, liver index, and total cholesterol. 16S rRNA sequencing showed that Bacillus sp. DU-106 intervention significantly increased bacterial richness and particularly increased the genus abundance of Turicibacter, Acinetobacter, Brevundimonas, and Bacillus and significantly decreased the abundance of Ralstonia. Metabolomic data further indicated that the supplementation of Bacillus sp. DU-106 remarkably changed the gut metabolic profiles of hypercholesterolemic rats and, in particular, elevated the metabolites of indole-3-acetate, methylsuccinic acid, creatine, glutamic acid, threonine, lysine, ascorbic acid, and pyridoxamine. Spearman's correlation analysis showed the close relation between the different genera and metabolites. In conclusion, Bacillus sp. DU-106 supplement ameliorated high-fat diet-induced hypercholesterolemia and showed potential probiotic benefits for the intestine.KEY POINTS: • A novel potential probiotic Bacillus sp. DU-106 ameliorated hypercholesterolemia in rats. • Bacillus sp. DU-106 supplement regulated gut microbiome structure and richness. • Bacillus sp. DU-106 supplement changed metabolic profiles in high-fat diet rats. • Significant correlations were observed between differential genera and metabolites.

2021-04-08 | MTBLS1168 | MetaboLights

Brevundimonas sp. B9D7B

Project description:Brevundimonas sp. B9D7B Genome sequencing

| PRJNA632180 | ENA

Brevundimonas sp. PAMC22021

Project description:Brevundimonas sp. PAMC22021 Genome sequencing

| PRJNA748182 | ENA

Brevundimonas sp. 'scallop'

Project description:Brevundimonas sp. 'scallop' Genome sequencing

| PRJNA529960 | ENA

Brevundimonas sp. AAP58

Project description:Brevundimonas sp. AAP58 Genome sequencing

| PRJNA255559 | ENA

Expression data from NP366-374/Db and PA224-233/Db CD103 positive and negative T-cells

Project description:To investigate the role of TCR-pMHC interaction in regulating lung tissue-resident CD8 T cell differentiation, polyclonal responses were compared against NP366-374/Db and PA224-233/Db, two immunodominant epitopes that arise during influenza A infection. To characterize the molecular programs associated with the lung tissue-resident CD8 T cell subpopulations, we measured by microarray the global gene transcriptional profile of NP366-374/Db CD103+ and NP366-374/Db CD103-, PA224-233/Db CD103+, PA224-233/Db CD103- lung resident T cells.

2017-11-29 | GSE107448 | GEO

Sinorhizobium medicae strain:374

Project description:Sinorhizobium medicae 374 Resequencing

| PRJNA499399 | ENA

Brevundimonas sp. SPF441

Project description:Brevundimonas sp. SPF441 Genome sequencing and assembly

| PRJNA580507 | ENA

Brevundimonas sp. CS1

Project description:Brevundimonas sp. CS1 Genome sequencing and assembly

| PRJNA703419 | ENA